Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer
Authors:
- Charles J. RyanCRCharles J. Ryan
- Christopher M. HaqqCHChristopher M. Haqq
- Jeffrey SimkoJSJeffrey Simko
- Daisuke F. NonakaDNDaisuke F. Nonaka
- June M. ChanJCJune M. Chan
- Vivian WeinbergVWVivian Weinberg
- Eric J. SmallESEric J. Small
- Ira D. GoldfineIGIra D. Goldfine
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 25 (2) , 134-140
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Gene expression profiling identifies clinically relevant subtypes of prostate cancerProceedings of the National Academy of Sciences, 2004
- Role of stroma in carcinogenesis of the prostateDifferentiation, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- The IGF-I Receptor in Cancer ResearchExperimental Cell Research, 1999
- Tyrosine Kinases Expressed in Vivo by Human Prostate Cancer Bone Marrow Metastases and Loss of the Type 1 Insulin-Like Growth Factor ReceptorThe American Journal of Pathology, 1999
- INTERACTIONS OF A MONOCLONAL ANTIBODY TO THE INSULIN RECEPTOR WITH RECEPTORS FOR INSULIN-LIKE GROWTH FACTORSEndocrinology, 1983